Statistics from Altmetric.com
The University of North Carolina School of Medicine in Chapel Hill recently received a 5-year $500,000 unrestricted neuroscience research grant from the Bristol-Myers Squibb Co. for research in the neurobiology, pharmacology, and treatment of schizophrenia and related psychotic disorders. Jeffrey A. Lieberman, MD, a world leader in the field of psychiatry and schizophrenia, will supervise and serve as principal investigator of the grant. Dr. Lieberman is the Thad and Alice Eure Distinguished Professor of Psychiatry, Pharmacology, and Radiology and …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.